Latest Breaking News On - Enhanced liver fibrosis - Page 1 : comparemela.com

iLFT Platform Helps Detect Chronic Liver Disease

The intelligent Liver Function Testing (iLFT) platform automatically determines which patients should get follow-on testing and, if needed, subsequent referral to secondary care.

Scottish bordersUnited kingdomDamien leithLiver function testingEuropean associationEnhanced liver fibrosisNinewells hospital

Novel Intelligent Liver Function Test Platform Improves Liver Disease Diagnosis

iLFT is now an essential, highly utilized tool at one U.K. primary care system

Scottish bordersUnited kingdomKatherine kahnDamien leithRichard parkerUniversity of dundeeUk national health servicesHealth servicesNinewells hospitalMedical schoolEuropean associationEnhanced liver fibrosisFibrosis scoreLeeds teaching hospitalsMedpage today

Gilead Sciences, Inc : Gilead to Present Latest Research Across Key Liver Disease Indications at the European Association for the Study of the Liver Congress 2024

Key Findings from PBC, HDV, HCV, HBV and MASH/Fibrosis Studies Affirm Commitment to Drive Life-changing Science in Liver Disease - Gilead Sciences, Inc. (Nasdaq:GILD) today announced new research

Foster cityUnited statesFrank duffJacquie rossEpatitec mettiamociMeaghan smithGilead on twitter sciencesGilead sciences in liver diseaseGilead sciencesLove your liver campaignDrug administrationEuropean commissionGilead public affairsExchange commissionGilead sciences incWorld health organization

Gilead to Present Latest Research Across Key Liver Disease Indications at the European Association for the Study of the Liver Congress 2024

Gilead to Present Latest Research Across Key Liver Disease Indications at the European Association for the Study of the Liver Congress 2024
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesFoster cityFrank duffEpatitec mettiamociGilead sciences in liver diseaseEuropean commissionGilead sciences incLove your liver campaignExchange commissionGilead sciencesDrug administrationWorld health organizationEuropean associationSenior vice presidentVirology therapeutic area headHepatitisc let

Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results

BEACON-IPF pivotal, adaptive Phase 2b/3 trial design implementation significantly accelerates bexotegrast development in IPF Data from completed 12 week Phase 2a imaging trial measuring.

United statesChristopher keenanBernard coulieEuropean unionOxford financeCorporate communicationsDrug administrationPliant therapeutics incAustralia research ethics committeeEuropean medicines agencyChief executive officerMassachusetts generalEnhanced liver fibrosisResearch ethics committeePliant therapeuticsFast track designation